Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Index values are published at set times by providers, aiding timely decision-making. This intro explains publication schedules and access methods.
19,766 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
In 2026, investors face a clash between disruption and durability: Archer Aviation as a high-growth upstart and Boein...
GameStop's Ryan Cohen signals a continued bid to acquire eBay despite board pushback, detailing strategy, financing, ...
A major insider sale at TransMedics grabbed attention after the stock slumped about 45%. This article dives into what...
A private liberal arts college in the Pacific Northwest launches a four-year tuition cap set at 10% of a family’s inc...
If you’re building a resilient income plan, Realty Income stock offers dependable monthly dividends and a carefully c...
When a rocket-ride valuation grabs headlines, it’s easy to chase the hype. This guide breaks down spacex's market qui...
Qualcomm rolls out a five year plan to compete with Nvidia in AI data center chips, aiming for multi billion dollar A...
Adobe data shows Prime Day online spending near $26.4 billion, beating forecasts by a slim margin. The four-day event...
Pi Network’s PI token fell about 5% after Pi2Day hype, even as Bitcoin moved back to the $60,000 level. The market re...
When space stocks surge, investors want to know why. This article breaks down the drivers behind Planet Labs stock we...
A sharp price drop followed by a sizable insider sale can mean many things. This guide walks through what to watch in...